HITIQ Launches PROTEQT Into North America Through Exclusive Canadian Distribution Deal
HITIQ Limited (ASX: HIQ) has launched its PROTEQT™ North American market strategy, appointing Canadian hockey leader Rick Shultz as exclusive distributor across Canada, with non-exclusive rights in the United States. The agreement unlocks immediate access to Canada’s 607,000+ registered hockey players, the world’s second-largest hockey market, and leverages Shultz’s extensive network from grassroots to elite levels.
The strategy incorporates both institutional and consumer sales channels, enabling PROTEQT™ to supply leagues, clubs, and individual athletes with advanced concussion-management technology. Initial commercial traction includes a founding order and a live pilot program at elite-level hockey, validating PROTEQT™’s real-world performance.
HITIQ’s manufacturing scale is preparing for up to 100,000 units in 2026, supporting long-term North American growth. The partnership strengthens HITIQ’s global expansion framework, providing a reference market for future uptake across collegiate, professional, and community sports.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au.au
Daily Dose of Buy, Sell & Hold recommendations before the market opens.
HITIQ Launches PROTEQT Into North America Through Exclusive Canadian Distribution Deal
HITIQ Limited (ASX: HIQ) has launched its PROTEQT™ North American market strategy, appointing Canadian hockey leader Rick Shultz as exclusive distributor across Canada, with non-exclusive rights in the United States. The agreement unlocks immediate access to Canada’s 607,000+ registered hockey players, the world’s second-largest hockey market, and leverages Shultz’s extensive network from grassroots to elite levels.
The strategy incorporates both institutional and consumer sales channels, enabling PROTEQT™ to supply leagues, clubs, and individual athletes with advanced concussion-management technology. Initial commercial traction includes a founding order and a live pilot program at elite-level hockey, validating PROTEQT™’s real-world performance.
HITIQ’s manufacturing scale is preparing for up to 100,000 units in 2026, supporting long-term North American growth. The partnership strengthens HITIQ’s global expansion framework, providing a reference market for future uptake across collegiate, professional, and community sports.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com.au.au